1-3 of 3
Francisco J Novo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lymphoma-Derived IL-10 Is a Key Immunomodulatory Factor at the Tumor Microenvironment of Activated B-Cell Diffuse Large B-Cell Lymphoma and Influences In Vivo Responses to Immunotherapy

Marcos Garcia-Lacarte, Sara C Grijalba, Francisco J Novo, Adrián Arnaiz-Leché, Javier Melchor, Marién Pascual, Enrique Goñi, Sandra Morales-Sánchez, María A Burrell, Oscar Blanco, Iñigo Clemente-Larramendi, Jose A Martinez-Climent, Noelia Casares, Juan J Lasarte, Pablo Sarobe, Miguel Canales, Sergio Roa
Journal: Blood
Blood (2023) 142 (Supplement 1): 716.
https://doi.org/10.1182/blood-2023-177612
Published: 2023
Journal Articles

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

Ion Cristóbal, Francisco J. Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente, José Rifon, Francisco J. Novo, Eva Bandres, María J. Calasanz, Carmelo Bernabeu, María D. Odero
Journal: Blood
Blood (2010) 115 (3): 615–625.
https://doi.org/10.1182/blood-2009-06-227363
Published: 2010
Includes: Supplemental data
Journal Articles

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma

Brief Report
José I. Martı́n-Subero, Stefan Gesk, Lana Harder, Takashi Sonoki, Philip W. Tucker, Brigitte Schlegelberger, Werner Grote, Francisco J. Novo, Marı́a J. Calasanz, Martin L. Hansmann, Martin J. S. Dyer, Reiner Siebert
Journal: Blood
Blood (2002) 99 (4): 1474–1477.
https://doi.org/10.1182/blood.V99.4.1474
Published: 2002